Does USTEKINUMAB Cause Hypersensitivity? 3,937 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 3,937 reports of Hypersensitivity have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 4.6% of all adverse event reports for USTEKINUMAB.
3,937
Reports of Hypersensitivity with USTEKINUMAB
4.6%
of all USTEKINUMAB reports
1,358
Deaths
1,840
Hospitalizations
How Dangerous Is Hypersensitivity From USTEKINUMAB?
Of the 3,937 reports, 1,358 (34.5%) resulted in death, 1,840 (46.7%) required hospitalization, and 1,685 (42.8%) were considered life-threatening.
Is Hypersensitivity Listed in the Official Label?
Yes, Hypersensitivity is listed as a known adverse reaction in the official FDA drug label for USTEKINUMAB.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Hypersensitivity?
ETANERCEPT (10,846)
ADALIMUMAB (10,641)
METHOTREXATE (9,799)
TOCILIZUMAB (9,076)
ABATACEPT (8,945)
INFLIXIMAB (8,519)
RITUXIMAB (8,408)
ADAPALENE (8,356)
LEFLUNOMIDE (7,926)
CERTOLIZUMAB PEGOL (7,353)
Which USTEKINUMAB Alternatives Have Lower Hypersensitivity Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE